Should Antipsychotics' Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults' Behavioral Symptoms in Short-Staffed Units?

Rollo, Alex; Kar, Jeena; Suryadevara, Uma; Camp, Mary

Rollo, Alex; Kar, Jeena; Suryadevara, Uma; Camp, Mary.

Afiliação

Rollo A; Psychiatry resident at the University of Texas Southwestern Medical Center in Dallas.
Kar J; Fourth-year resident in the University of Florida General Psychiatry Program in Gainesville.
Suryadevara U; Associate professor and the Geriatric Psychiatry Fellowship Program director at the University of Florida College of Medicine in Gainesville.
Camp M; Associate professor in the Department of Psychiatry at the University of Texas Southwestern Medical Center in Dallas.

AMA J Ethics ; 25(10): E725-732, 2023 10 01.

Article em En | MEDLINE | ID: mdl-37801055

RESUMO

This commentary on a case considers risks and benefits of pharmacological and nonpharmacological management of agitation in patients with dementia. Specifically, it considers beneficence and nonmaleficence in treatment decisions that affect both patients and staff as well as autonomy and surrogate decision making.

Assuntos

Antipsicóticos; Humanos; Idoso; Antipsicóticos/efeitos adversos; Beneficência; Sintomas Comportamentais

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antipsicóticos Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: AMA J Ethics Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google